Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics

For Immediate Release

Chicago, IL – August 14, 2025– Today, Zacks Investment Ideas feature highlights IonQ IONQ, Hims and Hers HIMS, Eli Lilly LLY and TransMedics Group TMDX.

3 Unusual Insider Transactions You Should Know About

Insider transactions, particularly insider buys, are a valuable tool for investors to monitor because they can provide insight into how the company's management team feels about the company's future. Additionally, insider buy transactions may provide peace of mind for investors, signaling that management has skin in the game and is willing to bet on themselves.

For instance, in a March 25^th article, I pointed out that two IonQ insiders made unusually large purchases of IONQ stock. The insider buys were particularly attention-grabbing for a few reasons, including the larger-than-normal size of the transactions and the fact that more than one insider was buying shares. Since then, shares have risen nearly 60% and have doubled in value at one point.

Insider Trades: What to look for

Investors need to understand that when it comes to analyzing insider transactions, not all are equal. Insider buys typically hold more weight for investors because insiders only buy stock for one reason – they believe the share price will increase.

Conversely, insider sales are less meaningful because insiders may have pre-planned sales or may be selling stock for personal reasons (though there are, of course, exceptions to the rule). The two most important factors to look for are time and size. If an insider buys stock for the first time in years and buys a lot, it's usually a good omen for the stock.

3 Recent Insider Transactions to Watch

HIMS CEO Makes Largest Insider Sale in Company History

Recent filings show that Hims and Hers CEO Andrew Dudum sold more than $30 million worth of HIMS stock. Unfortunately, the insider sale is not a one-off instance. Insiders have sold a combined $199 million worth of shares during the past year!

In addition to the troubling insider sells, HIMS has been a choppy, news-driven, and difficult stock to trade.

LLY Insiders Buy the Dip

Pharma giant Eli Lilly shares suffered a 14% drop on August 7^th after a worse-than-anticipated earnings report. However, a slew of LLY insiders see the dip as an opportunity to scoop up cheap shares. Since the EPS report, five insiders, including CEO David A. Ricks, bought nearly $3 million worth of stock. The large multiple buys may mean that the stock is nearing a bottom.

TMDX CEO Bets Big

The latest insider transaction filings show that TransMedics Group CEO & President Waleed Hassanein bought nearly $2 million worth of his company's stock. The transaction marks the first insider buy of the medical products company since 2023.

Bottom Line

While no single indicator can guarantee a stock's performance, the pattern of insider transactions can offer a powerful glimpse into a company's prospects.

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research